FCER1A and neoplasm: In addition to the small intestine, co-expression of the α- and γ-chain was observed in 4/6 FcεRIα positive colon samples from tumor patients and in 2/3 colon sections from gastrointestinal inflammation patients (Table 2; Figure 3B, E).